Related Experiment Videos
Somatostatins and their role in thyroid cancer
1Department of Otolaryngology Head and Neck Surgery, Hull Royal Infirmary, Hull, UK. rjaeathome@aol.com
Abstract:
Somatostatins are neuropeptides that exert a downregulatory effect on various physiological processes. Somatostatin analogues are used in the imaging and management of various tumour types. Their role in thyroid cancer has not as yet been fully elucidated. A systematic review of the literature using the keywords thyroid, cancer and somatostatin revealed 263 references. This paper summarizes the current knowledge of the role of somatostatins in thyroid cancer and assesses their future potential.
Insights
Somatostatins and their analogues are crucial in managing various tumors. Their specific role in thyroid cancer requires further elucidation, prompting a review of current knowledge and future potential.
Area of Science:
- Endocrinology
- Oncology
- Neuropeptide research
Background:
- Somatostatins are neuropeptides with known downregulatory physiological effects.
- Somatostatin analogues are established tools in imaging and managing diverse tumor types.
- The precise role of somatostatins in thyroid cancer remains incompletely understood.
Purpose of the Study:
- To summarize current knowledge on somatostatins in thyroid cancer.
- To assess the future potential of somatostatins in thyroid cancer management and imaging.
Main Methods:
- Systematic literature review.
- Keywords used: thyroid, cancer, somatostatin.
- Analysis of 263 identified references.
Main Results:
- The review synthesizes existing data on somatostatin's involvement in thyroid cancer.
- Identifies gaps in current understanding and highlights areas for future research.
Conclusions:
- Somatostatins show potential in thyroid cancer diagnostics and therapeutics.
- Further research is warranted to fully elucidate and leverage their role.